Shelter Pharma Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	82.02	72.37	62	52.06	18.37	-2.39
Depreciation & Amortization	3.58	2.68	2.46	1.64	1.69	1.16
Other Amortization	0.01	0.01	-	-	-	-
Provision & Write-off of Bad Debts	-1.5	-	3	-	-	-
Other Operating Activities	10.09	-0.02	5.55	18.55	5.46	0.06
Change in Accounts Receivable	-14.59	-6.25	-6.55	-65.89	-8.46	-1.46
Change in Inventory	-68.56	-29.66	-20.66	-22.9	-16.59	2.91
Change in Accounts Payable	2.95	5.37	2.47	1.45	0.11	0.52
Change in Other Net Operating Assets	1.28	10.32	-67.88	5.46	4.59	-3.64
Operating Cash Flow	15.27	54.82	-19.62	-9.64	5.17	-2.83
Capital Expenditures	-28.06	-26.51	-8.52	-0.04	-6.05	-0.09
Investment in Securities	-	-	-	-	-0.01	-
Other Investing Activities	0.1	0.06	0.01	0.02	0	0.02
Investing Cash Flow	-154.51	-71.28	-45.44	1.13	-8.52	0.34
Long-Term Debt Issued	-	3.58	0.93	4.8	0.65	-
Net Debt Issued (Repaid)	0.93	3.58	0.93	4.8	0.65	-
Issuance of Common Stock	-	-	109.12	-	-	4.8
Common Dividends Paid	-3.82	-3.82	-	-	-	-
Other Financing Activities	134.95	0.49	-	-2.01	-	-
Financing Cash Flow	132.07	0.26	110.06	2.79	0.65	4.8
Miscellaneous Cash Flow Adjustments	-	-	-	9	-0	-
Net Cash Flow	-7.18	-16.2	45	3.28	-2.7	2.32
Free Cash Flow	-12.8	28.32	-28.14	-9.68	-0.88	-2.92
Free Cash Flow Margin	-2.14%	5.59%	-7.03%	-2.68%	-0.29%	-1.30%
Free Cash Flow Per Share	-0.80	2.45	-2.43	-1.25	-0.11	-0.39
Cash Income Tax Paid	17.9	24.36	15.6	-	-	-
Levered Free Cash Flow	-25.97	16.1	-52.69	-21.17	-3.05	-0.07
Unlevered Free Cash Flow	-25.97	16.1	-51.37	-21.13	-2.66	0.01
Change in Working Capital	-78.93	-20.22	-92.62	-81.89	-20.35	-1.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.